Mycobacterial Implications in Crohn’s and Chronic Inflammatory Diseases
September 21 & 22, 2018
Lawrence Hall of Science | Berkeley, California
For thousands of years, mycobacterial species have caused some of the most insidious diseases in human history, such as tuberculosis and leprosy.
In September 2018, Human Paratuberculosis Foundation (HPF) and a group of dedicated researchers will bring their experience and expertise to Berkeley, California for a two-day conference. Featuring presenters and experts from across the globe, this conference has been specifically designed to explore the role that mycobacteria, particularly Mycobacterium avium spp. paratuberculosis (MAP), may play in Crohn’s disease, Type 1 diabetes, multiple sclerosis and other chronic conditions.
Friday, September 21st will be open to the general public and health care professionals. Presentations from mycobacterial experts around world will discuss the latest developments in the field. Featured presenters include Prof. Thomas Borody (Australia), Dr. William Chamberlin (USA), John Aitken (New Zealand), Qu Biologics (Canada) and Dr. Jonathan Budzik from the Cox Lab (Berkeley, CA).
On Saturday, September 22nd, entry will be limited to doctors, researchers and health care professionals. An update on the Joint MAP Testing Study will begin the day, followed by panel discussions, and a think tank style working session.
Lunch will be provided each day at no additional cost. Net proceeds will support high quality, innovative mycobacterial research and education.
